These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19934663)

  • 1. TGFbeta and cancer initiating cells.
    Seoane J
    Cell Cycle; 2009 Dec; 8(23):3787-8. PubMed ID: 19934663
    [No Abstract]   [Full Text] [Related]  

  • 2. Context-dependent action of transforming growth factor β family members on normal and cancer stem cells.
    Caja L; Kahata K; Moustakas A
    Curr Pharm Des; 2012; 18(27):4072-86. PubMed ID: 22630079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Snail regulates BMP and TGFβ pathways to control the differentiation status of glioma-initiating cells.
    Caja L; Tzavlaki K; Dadras MS; Tan EJ; Hatem G; Maturi NP; Morén A; Wik L; Watanabe Y; Savary K; Kamali-Moghaddan M; Uhrbom L; Heldin CH; Moustakas A
    Oncogene; 2018 May; 37(19):2515-2531. PubMed ID: 29449696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.
    Piccirillo SG; Reynolds BA; Zanetti N; Lamorte G; Binda E; Broggi G; Brem H; Olivi A; Dimeco F; Vescovi AL
    Nature; 2006 Dec; 444(7120):761-5. PubMed ID: 17151667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor, a Transforming Growth Factor β Rheostat That Controls Murine Treg Cell/Th17 Cell Differentiation and the Development of Autoimmune Arthritis by Reducing Interleukin-2 Signaling.
    Postigo J; Iglesias M; Álvarez P; Jesús Augustin J; Buelta L; Merino J; Merino R
    Arthritis Rheumatol; 2016 Jun; 68(6):1551-62. PubMed ID: 26714180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
    J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling.
    Garulli C; Kalogris C; Pietrella L; Bartolacci C; Andreani C; Falconi M; Marchini C; Amici A
    Cell Signal; 2014 Feb; 26(2):352-62. PubMed ID: 24280125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling mesenchymal stem cell differentiation by TGFBeta family members.
    Roelen BA; Dijke Pt
    J Orthop Sci; 2003; 8(5):740-8. PubMed ID: 14557946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear fusion of signaling pathways.
    Janknecht R; Hunter T
    Science; 1999 Apr; 284(5413):443-4. PubMed ID: 10232991
    [No Abstract]   [Full Text] [Related]  

  • 11. Triggering TGFbeta and notch signalling cross-talk.
    Soares R; Alçada MN; Azevedo I
    Bioessays; 2005 Jul; 27(7):763. PubMed ID: 15954101
    [No Abstract]   [Full Text] [Related]  

  • 12. The TGFβ superfamily in cardiac dysfunction.
    Wu J; Jackson-Weaver O; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2018 Apr; 50(4):323-335. PubMed ID: 29462261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300.
    Nakashima K; Yanagisawa M; Arakawa H; Kimura N; Hisatsune T; Kawabata M; Miyazono K; Taga T
    Science; 1999 Apr; 284(5413):479-82. PubMed ID: 10205054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor β and bone morphogenetic protein actions in brain tumors.
    Caja L; Bellomo C; Moustakas A
    FEBS Lett; 2015 Jun; 589(14):1588-97. PubMed ID: 25957771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes.
    Izumi M; Masaki M; Hiramoto Y; Sugiyama S; Kuroda T; Terai K; Hori M; Kawase I; Hirota H
    J Mol Cell Cardiol; 2006 Feb; 40(2):224-33. PubMed ID: 16427075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP and LIF signaling coordinately regulate lineage restriction of radial glia in the developing forebrain.
    Li H; Grumet M
    Glia; 2007 Jan; 55(1):24-35. PubMed ID: 17001659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFβ Family Signaling Pathways in Pluripotent and Teratocarcinoma Stem Cells' Fate Decisions: Balancing Between Self-Renewal, Differentiation, and Cancer.
    Gordeeva O
    Cells; 2019 Nov; 8(12):. PubMed ID: 31771212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
    Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
    J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling tumor suppressor networks with in vivo RNAi.
    Braun CJ; Hemann MT
    Cell Stem Cell; 2013 Jun; 12(6):639-41. PubMed ID: 23746971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase signalling pathways involved in the up-regulation of the rat alpha1(I) collagen gene by transforming growth factor beta1 and bone morphogenetic protein 2 in osteoblastic cells.
    Palcy S; Goltzman D
    Biochem J; 1999 Oct; 343 Pt 1(Pt 1):21-7. PubMed ID: 10493907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.